trastuzumab patent expiry.pdf - PDFQueen - PDF Search engine. Free unlimited pdf search and download.

by SCAA Thomson - 2007palivizumab and trastuzumab. This list of products may be incomplete, however; patent analysts ... original Cabilly patent (US-04816567, expired March 2006) ...

http://www.biomedcentral.com/content/pdf/cd-803117.pdf

by P Steele - 2002before the expiry of Roche's basic patent! It would seem that deeper investigation is required ... (trastuzumab) was revealed on September 6th 2002, finding ...

http://www.biomedcentral.com/content/pdf/cd-466138.pdf

by J Pisani - Cited by 7

http://www.ableindia.org/biosimilars.pdf

Trastuzumab - Pipeline Selector. Description: Pipeline Selector: single-drug access to essential competitor, regulatory and patent expiry ...

http://www.researchandmarkets.com/reports/688636/trastuzumab_pipeline_selector.pdf

sales and patent expiry information on the products identified as profitable targets for biosimilars .... Table 2.61 Candidate biosimilars (trastuzumab) ...

http://www.researchandmarkets.com/reports/577399/a_guide_to_biosimilars_biogenerics_and.pdf

Patent expiry dates were determined from the Health. Canada Patent Register3 for the cancer drugs ..... anthracyclines, taxanes and trastuzumab, 15-May-09 ...

http://www.canceradvocacy.ca/reportcard/2009/pdf/Cancer Drugs - Kong Khoo et al.pdf

(trastuzumab). US $3175. 25 September. 1998. From the Genentech 2007 Form 10-K · (dated 26 Feb. 2008): Identified U.S.. Patent(s). Expiry. 6339142 ...

http://www.ftc.gov/os/comments/healthcarecompissues/537778-00039.pdf

24 Mar 2010 ... Following patent expiry, the value creation and capture .... many oncology drugs, trastuzumab was first tested in later- ...

http://theoncologist.alphamedpress.org/cgi/reprint/15/suppl_1/49.pdf

Patent expiry represents a critical milestone in the life of pharmaceutical and agrochemical products .... bevacizumab, palivisumab, omalizumab, trastuzumab ...

http://www.stockholm-network.org/downloads/events/Patent_Term_Extensions_Alison_Blakey_Prosidion_Ltd.pdf

28 Apr 2009 ... Trastuzumab. Insulin 2nd generation .... Impact of Patent Linkage. AT PATENT EXPIRY: NO LAUNCH. OF GENERIC MEDICINES. Munich, March 09 ...

http://www.febelgen.be/documents/FeBelGen-GME-Greg-Perry-090428.pdf

projected to stay near current levels until the expiration of the patent in 2006. .... trastuzumab. 1399 Metastatic breast cancer with HER2 overexpression ...

http://www.chugai-pharm.co.jp/html/meeting/pdf/020130e_1_booklet.pdf

ogy agents with Herceptinо [trastuzumab], .... Biologics and Patent Expiration. Currently, no regulatory pathway for FDA approval of generic biologics is in ...

http://www.oncbiz.com/documents/OBRjune07_Generics(1).pdf

1 Jan 2010 ... Young product portfolio (Material patent expiry risk in 5 to 8 years) .... R3502(trastuzumab-DM1). Dacetuzumab. Dulanermin ...

http://www.roche.com/irp100111.pdf

Young product portfolio (Material patent expiry risk in 5 to 8 years) .... R3502(trastuzumab-DM1). Dacetuzumab. Dulanermin. R1507(IGF-1R mAb) ...

http://www.roche.com/irp091117.pdf

analgesic and trastuzumab is an antibody used to treat women with breast ..... patent expires, other companies can sell a generic drug, which is an exact ...

http://biochemistry.ucsf.edu/programs/ptf/Prologue Links/Intro Pharmacology.pdf

20 Dec 2009 ... combines Herceptin (trastuzumab) with DM1 a powerful chemo-toxin, .... US patent expiry and NHI price change issues, most Japanese drug ...

http://www.pelhamsmithers.com/yahoo_site_admin/assets/docs/Japan_Phama_09_12_20f.353214142.pdf

14 Nov 2008 ... Trastuzumab. Epoetin beta. Epoetin alfa. Infliximab. Etanercept. Darbepoietin ..... Patent Expiry. Target Biologics Market Share & Patent ...

http://www.elgabiotech.de/images/Colloquium2008/Presentations/5GitaSharma.pdf

27 Mar 2010 ... opportunity cost of funding trastuzumab, in ... two years before the patent for Imigran expired, has no proved additional clinical ...

http://www.bmj.com/cgi/section_pdf/340/feb25_1/c572.pdf

With the patent expiry on first-generation. MAB products approaching, .... and trastuzumab both scored low on the health and safety risk and, in our view, ...

http://www.pharmj.com/pdf/hp/200802/hp_200802_monoclonal.pdf

9 Mar 2010 ... trastuzumab-DM1. Phase 2 and 3. Breast HER2+ Cancer. ✓ On November 16, 2009, ..... Inventory on hand at Queen patent et al. expiry 12/2014 ...

http://www.pdl.com/pdf/PDL_BioPharma_Presentation_at_Cowen_Conference_Mar_9_2010-final.pdf

trastuzumab-DM1. Phase 2 and 3. Breast HER2+ Cancer. Lucentis. Approved ..... Inventory on hand at Queen patent et al. expiry 12/2014 ...

http://www.pdl.com/pdf/PDLCompanyOverviewMarch2010.pdf

on the market have seen their patent protection expired which led to the ... TNF α-inhibitors for inflammatory diseases and trastuzumab for breast cancer ...

http://iospress.metapress.com/index/9712722KM81VU17T.pdf

years from normal patent expiry. • Petition for extension, setting out claim for ... Daclizumab. Bevacizumab. Palivisumab. Omalizumab. Trastuzumab ...

http://www.pharmalaw-events.com/presentations/2007/06 - Gordon Wright.pdf

The patent of Pravachol expired on April 30, 2006 and Watson has ... documented ErbB2 (HER2) over expression and whose disease progressed following treatment with trastuzumab .... version after its patent expiry which recorded a sale of ...

http://www.ipapharma.org/pp/Pharma_Professional_May_2006.pdf

products, following patent expiry. Intas has a biosimilar product pipeline ..... an aromatase inhibitor has not been compared to a trastuzumab-containing ...

http://www.ipapharma.org/pp/IPA February 10.pdf

USA Patent Expiry. EU Patent/SPC Expiry. Amgen. Aranesp darbopoetin. 2012 - 2015 ... trastuzumab. 2013 - 2018. 2010 - 2014. Genentech. Avastin bevacizumab ...

http://www.gii.co.jp/conference/biosimilars-asia10/catalog.pdf

After expected patent expiry of insulin analogues in major market s ... Herceptin (trastuzumab, Genentech/Roche). Monoclonal antibody ...

http://www.bharatbook.com/upload/BiosimilarsFollowonBiologics.pdf

Strategies to allay the challenge of patent expiry, generic incursion and ... Herceptin (trastuzumab). Anti-emetics. - Kytril (granisetron) and Zofran ...

http://researchandmarkets.co.uk/reports/238304/cancer_market_top_20_drugs_supportive_care.pdf

3 Sep 2008 ... Follow-on versions of biopharmaceuticals after patent expiry ... interferons, trastuzumab, rituximab, infliximab and etanercept ...

http://www.biosimilar.sandoz.de/assets/content/de/files/2008-09-Sandoz-Day_Teissl-Presentation.pdf

(Patent expiration). • Approval process. (long + difficult) ... Trastuzumab. IgG1K humanized,. aHER2 Kd = 5 nM .... Trastuzumab. Herceptin Antibody ...

http://www.ovariancancer.unimore.it/PBauknecht.pdf

(trastuzumab), Genentech/Roche's Non-Hodgkin's lymphoma and rheumatoid arthritis treatment ..... (interferon beta-1a) approaches patent expiry. ...

http://www.bpcouncil.com/uploads/BPCouncil-Research-Room-BayervsAbbott-An IP Perspective.pdf

Trastuzumab, as part of a treatment regimen containing doxorubicin, ..... and expects to commence marketing of this product upon patent expiry in February ...

http://flasco.stateaffiliates-asco.org/2007 UPDATES 11262007.PDF

8 Nov 2006 ... government to subsidise trastuzumab (Herceptin) by creating a special program. ... drug's patent is about to expire. ...

http://www.australianprescriber.com/upload/pdf/articles/837.pdf

Trastuzumab. Insulin 2nd generation. Source: IMS PADSS (MAT Q2 2006) ... Worldwide sales of expiring products in year of US patent expiry ...

http://www.esdegerilac.com/pdfler/ega2007sunumlar/A_Rummelt.pdf

oncology products Trastuzumab (Herceptin, Genentech-Roche, US$1.8bn) and .... The surge in generics together with the expected patent expiry of key ...

http://www.svssec.com/admin/ResearchPdf/1518822790_RR-SVS-Sec-01.pdf

4 May 2009 ... Trastuzumab. Insulin 2nd generation ..... AT PATENT EXPIRY: NO LAUNCH. OF GENERIC MEDICINES. Munich, March 09 ...

http://www.bgpharma.bg/userfiles/file/1 Greg Perry Opening.pdf

Significant competition and patent expiry will affect cytotoxic and anti- ... Trastuzumab (Herceptin). Breast cancer. $4.4 Billion. $5.8 Billion ...

http://genesis-biopharma.com/Presentation.pdf

by S Erb - 2006 - Cited by 1

http://www.technology-catalysts.com/pdf/TCI-PharmaTech-1006.pdf

market share after patent expiry since generic competition is weaker. ... Another example is Trastuzumab, which was funded through ...

http://annonc.oxfordjournals.org/cgi/reprint/18/suppl_3/iii55.pdf

by H Grabowski - 2007 - Cited by 8

http://www.aei.org/docLib/20070607_GrabowskiWorkingPaper.pdf

File Format: PDF/Adobe Acrobatby EC Saltzman - 2006payers in their push to switch patients to Zocor in anticipation of that product's patent expiry earlier this year. Although the industry has historically ...

http://www.windhover.com/ezine/pdf/long.pdf

Evista and Xigris until the patent expires in 2019. In. 2008 Evista had worldwide sales of $1.07 ..... whom had received trastuzumab and half who had not. ...

http://www.windhover.com/ezine/pdf/p090831.pdf

(trastuzumab) that interferes with the HER2/neu receptor. .... streamlined and as many antibodies move toward patent expiration. ...

http://www.trimarkpublications.com/samples/tmantibodiessample.pdf

24 Jul 2009 ... costs, and the impending patent expiration of blockbuster drugs (with a dearth of new .... (trastuzumab) for breast cancer, Biogen ...

http://www.biopharmconsortium.com/GEN_PIIAtt_0809.pdf

... 3 clinical study); NICE (guidance on the use of Trastuzumab - March 2002) ..... Note: Assumed 12 year patent expiry from U.S. launch; assumes U.S. half life of 9 months ... analyses; assumes flat volume from peak to patent expiry ...

http://www.trade.gov/td/health/phRMA/PhRMA - ANNEX D.pdf

Herceptin (Trastuzumab), for example, emerged from the cloning of the HER2 gene by Genentech .... soon face some patent expiration issues. The FDA and ...

http://www.cybermediaservicesdigitalmag.com/admin/magazines/vol3_issue2/BSA_pages/BSA_jan_Issue2_2008.pdf

Herceptin/ trastuzumab. hGH/somatropin. Enbrel/ etanercept. Rituxan/ rituximab ... Biotech drugs offer a huge market potential, also after patent expiry ...

http://www.biogenerix.com/publications/Visiongain_Biogenerics_TB_30_03_2006.pdf

28 Nov 2008 ... Herceptin (trastuzumab). Hoffmann-. La Roche .... Launch of first product. Expiry of SPC. Expiry of first patent ...

http://ec.europa.eu/competition/sectors/pharmaceuticals/inquiry/si.pdf

11 Feb 2010 ... due to the expiry of patent for Atorvastatin. ..... The first molecule will be conjugated Trastuzumab for the treatment of breast cancer. ...

http://myiris.com/shares/research/hdfc/BIOCON_20100211.pdf

rituximab, and trastuzumab). Ex- penditures on these 3 agents contin- .... Brain cancer. Asthma. Indication. Current Patent. Expiration Dateb ...

http://www.ajhp.org/misc/6a-SF_Hoffman-Vermeulen.pdf